CD8+ lymphocyte phenotype and cytokine production in long-term non-progressor and in progressor patients with HIV-1 infection

Clinical and Experimental Immunology

Volumn 105, Issue 2, 1996, Pages 220-224

  Zanussi, S ^a   Simonelli, C ^a   D'Andrea, M ^a   Caffau, C ^a   Clerici, M ^a   Tirelli, U ^a   De Paoli, P ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

CD28; CD8+ lymphocytes; CD95; HIV 1 non progression

Indexed keywords

CD28 ANTIGEN; CD8 ANTIGEN; CYTOKINE; FAS ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOFLUORESCENCE; MALE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0030017679     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-746.x     Document Type: Article

References (24)

1. Lifson AR, Rutherford GW, Jaffe HW. The natural history of human HIV infection. J Infect Dis 1988; 158:1360-7.
2. Phair JP. Variations in the natural history of HIV infection. AIDS Res Human Retrovir 1994; 10:883-5.
3. + T-cell levels. AIDS 1993; 7:1159-66.
4. Buchbinder SP, Katz MH, Hessol NA, O'Malley PM, Holmberg SD. Long-term HIV-1 infection without immunologic progression. AIDS 1994; 8:1123-8.
5. + lymphocytes. J Acquir Immune Defic Syndr and Hum Retrovirol 1995; 8:496-505.
6. Cao Y, Qin L, Zhang L, Safrit J, Ho DD. Virologie and immunologic characterization of long-term survivor of human immuno-deficiency virus type 1 infection. New Engl J Med 1995; 332:201-8.
7. Pantaleo G, Menzo S, Vaccarezza M et al. Studies in subjects with long-term non-progressive human immunodeficiency virus infection. New Engl J Med 1995; 332:209-16.
8. Giorgi JV, Liu Z, Hultin LE, Cumberland WG, Hennessey K, Detels R. J Acquir Immune Defic Syndr 1993; 6:904-12.
9. Clerici M, Shearer GM. The Th1-Th2 hypothesis in HIV infection: new insights. Immunol Today 1994; 15:575-81.
10. Romagnani S, Maggi E, Del Prete G. An alternative view of the Th1/Th2 switch hypothesis in HIV infection. AIDS Res Human Retrovir 1994; 10:iii-ix.
11. June CH, Ledbetter JA, Linsvey PS, Thompson CB. Role of the CD28 receptor in T cell activation. Immunol Today 1990; 11:211-6.
12. Levy JA. HIV pathogenesis and long-term survival. AIDS 1993; 7:1401-10.
13. Trauth BC, Klas C, Peters AM et al. Monoclonal antibody mediated-tumor regression by induction of apoptosis. Science (Wash. DC) 1984; 245:301-5.
14. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267:1456-62.
15. Alderson MR, Armitage RJ, Maraskovsky E et al. Fas transduces activation signals in normal human T lymphocytes. J Exp Med 1993; 178:2231-5.
16. Oyaizu N, McCloskey TW, Than S, Hu R, Kalyamaraman WS, Pahwa S. Cross linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-γ and tumor necrosis factor-α secretion. Blood 1994; 84:2622-31.
17. Mosmann TR, Chernwisnki H, Bond MW, Giedlin MA, Coffman RL. Two types of murine Th cell clone. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1988; 136:2348-57.
18. Salgame P, Abrams JS, Clayberger C et al. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 1991; 254:279-82.
19. + T cell clones in human immunodeficiency virus infection. J Exp Med 1994; 180:2407-11.
20. Brinchmann JE, Dobloug JH, Heger BH, Haaheim LL, Sannes M, Egeland T. Expression of costimulatory molecule CD28 on T cells in human immunodeficiency virus type 1 infection: functional and clinical correlations. J Infect Dis 1994; 169:730-8.
21. + T cells from HIV infected persons. J Immunol 1994; 153:412-20.
22. Pandolfi F, Oliva A, Sacco G et al. Fibroblast-derived factors preserve viability in vitro of mononuclear cells isolated from subjects with HIV-1 infection. AIDS 1993; 7:323-9.
23. Owen-Schaub LB, Yonehara S, Crump WL, Grimm EA. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol 1992; 140:197-206.
24. Graziosi C, Pantaleo G, Gantt KR et al. Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV infected individuals. Science 1994; 265:248-52.